We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. Read more about our Privacy Policy.

I got it!

Featured Publishers

Publishers (8)

Our Business Priorities We believe in the importance of having a clear set of priorities to guide us through a turbulent and ever-changing environment. Our aim is to achieve long term sustainable growth and deliver value to all our stakeholders. Focus on patients We focus on developing innovative medicines and diagnostic tests that help patients live longer, better lives. Two-thirds of all diseases are either still not treated adequately or not treated at all. This medical need is enormous and better diagnostics and medicines can make a huge difference to the lives of millions of patients and their families. Excellence in science We strive to address unmet medical needs through excellence in science. Breakthroughs in science and technology increasingly allow us to find out precisely what is malfunctioning in the body and develop drugs to counter the problem. We focus on oncology, immunology, ophthalmology, infectious diseases and neuroscience, however we remain flexible and follow the science as new insights become available. Personalised Healthcare We combine our strengths in pharmaceuticals and diagnostics to better fit treatments to patients. When genetic differences can be identified, the efficacy and safety of medicines can be improved enormously. To this end we have a companion diagnostic strategy for every molecule we develop. Access to healthcare We aim to bring our medicines and diagnostic tests to as many people in need as possible. Every healthcare system comes with different challenges and we customise solutions for individual markets. We work with many different local partners to reduce barriers to accessing healthcare and establish innovative, sustainable ways to bring effective and affordable healthcare to patients. Great workplace We are committed to constantly strengthening and maintaining an excellent workplace where every person feels valued and respected and can grow to his or her full potential. Our people make our business. They discover, develop and manufacture our products and ensure they reach the patients who need them. We believe that the key to our success lies in our ability to attract, retain and motivate a highly skilled and diverse workforce. Sustainable value We run our business in a way that is ethical and aims to create long-term value for all stakeholders. We want to create value through developing medical solutions and we aim for as many people to benefit from them as possible. We believe that our success lies in our ability to develop strategies where both industry and society benefit in a sustainable way. Roche Pharma AG was founded 1897 as a pharmaceutical company in Grenzach, Germany, near Basel, where the headquarters, F. Hoffmann-La Roche AG, is located.
Open
IMI’s EBiSC project has established a centralised, not-for-profit human induced pluripotent stem cell (iPSC) bank providing researchers across academia and industry with access to scalable, cost-efficient and consistent, high quality iPSCs for use in research and medicines development. Since its creation in 2014, the bank has grown considerably and now provides a large range of iPSC lines and services to academics, non-profit organisations and companies. Projects generating iPSCs can also make their cell lines sustainable by depositing them in the EBiSC catalogue, ensuring secure long-term storage and simplified access and distribution. The new EBiSC2 project builds on the achievements of the original EBiSC project, including improving its services and providing new iPSC lines and differentiated cell products.
Open
The ESPR aims to promote paediatric research in Europe and encourage collaboration between different specialised fields of paediatrics to maintain paediatrics as a unified, scientifically orientated discipline.One of the ways ESPR achieves these goals is by organising its own annual congress and co-organising others. These prestigious paediatric meetings attract thousands of experts in all fields of paediatrics, providing them with networking opportunities and exposure to the latest available research, treatments and patient care.
Open
The German Cancer Research Center (known as the Deutsches Krebsforschungszentrum or simply DKFZ in German), is a national cancer research center based in Heidelberg, Germany. It is a member of the Helmholtz Association of German Research Centres, the largest scientific organization in Germany.
Open
Professional Congress Organiser - INTERPLAN specialises in organising small to large sized medical conferences and associated exhibitions. The Company is based in Munich with Offices in Hamburg, Leipzig and Berlin. Over the years Interplan has gained valuable expertise in the field of medical conference organising.
Open
The Academy of European Law (ERA) enables judges, lawyers in private practice, business and public administration, academics and others who encounter legal issues in their work to gain a wider and deeper knowledge of the diverse aspects of European law. Through conferences, seminars, study visits, language courses, training projects and publications, it serves as an interface between the European legal profession and the decision-making centres of Brussels, Luxembourg and Strasbourg.
Open
Global challenges require local solutions and global governance. Protecting the climate, biodiversity, air quality and freshwater resources needs international commitment and cooperation between all levels of government.ICLEI is an:Association of over 1,200 local governments that represents the interests of local authorities within the United Nations and at international policy forums.A movement driving positive change on a global scale through programmes and campaigns on local sustainability.A resource centre offering information, tools, networking, training and consulting services.ICLEI is the only network of sustainable cities operating worldwide. The organisation facilitates local government input to United Nations (UN), processes such as the UN Framework Conventions on Climate Change, and Biodiversity. In partnership with the UN and other organisations, as well as national governments, ICLEI puts in the groundwork for more ambitious and more responsible international commitments - and seeks global recognition and support for local action.
Open
We are developing innovative computerized Techniques for new processes, products and services.Life Sciences Cell Image Analysis and Interpretation Motion Analysis High-Content Screening Spectrum Analysis Computational Systems BiologyMultimedia Image Analysis Ontologies Video Recognition Image Data BasesData/Image/Web Mining Classification Clustering Case-Based ReasoningWorld Wide Web Recommendation Systems Behavioral Targeting Customer Profile Analysis Detection of rare/novel Events Internet of Things
Open